Brief: Abbvie And Xilio Therapeutics Announce Collaboration

Xilio Therapeutics

12/02/2025 12:41

Feb 12 (Reuters) - Abbvie  ABBV.N :
    * ABBVIE AND XILIO THERAPEUTICS ANNOUNCE COLLABORATION AND
OPTION
AGREEMENT TO DEVELOP NOVEL TUMOR-ACTIVATED IMMUNOTHERAPIES
    * ABBVIE INC - COLLABORATION TO DEVELOP MASKED T-CELL
ENGAGERS
    * ABBVIE INC - XILIO TO RECEIVE $52 MILLION UPFRONT,
ELIGIBLE FOR
UP TO $2.1 BILLION

Source text:  ID:nPn9Fv6m9a 
Further company coverage:  ABBV.N 

 ((Reuters.Briefs@thomsonreuters.com;))